Enrique Perez-Gutierrez

Enrique Perez-Gutierrez

Auto-generated profile, based on publicly available information

Enrique Perez-Gutierrez

Regional Office for the Americas of the World Health Organization, Washington, DC, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
OMOliver W. Morgan
Oliver W. Morgan
PAPhilip Abdelmalik
Philip Abdelmalik
EPEnrique Perez-Gutierrez
Enrique Perez-Gutierrez
IFIbrahima Socé Fall
Ibrahima Socé Fall
MKMasaya Kato
Masaya Kato
CIChikwe Ihekweazu
Chikwe Ihekweazu

9 February 2021 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
TBTheresa Bernardo
Theresa Bernardo
KSKurtis Edward Sobkowich
Kurtis Edward Sobkowich
RFRussell Othmer Forrest
Russell Othmer Forrest
LSLuke Silva Stewart
Luke Silva Stewart
MDMarcelo D'AGostino
Marcelo D'AGostino
Daniel GillisDaniel Gillis
Daniel Gillis
The emergence of COVID-19 spurred the formation of myriad teams to tackle every conceivable aspect of the virus and thwart its spread. Enabled by global digital connectedness, collaboration has become a constant theme throughout the pandemic, resulting in the expedition of the scientific process (including vaccine development), rapid consolidation of global outbreak data and statistics, and experimentation with novel partnerships. To document the evolution of these collaborative efforts, the authors collected illustrative examples as the pandemic unfolded, supplemented with publications from the JMIR COVID-19 Special Issue. Over 60 projects rooted in collaboration are categorized into five main themes: knowledge dissemination, data propagation, crowdsourcing, artificial intelligence, and hardware design and development. They highlight the numerous ways that citizens, industry professionals, researchers, and academics have come together worldwide to consolidate information and produce products to combat the COVID-19 pandemic. Initially, researchers and citizen scientists scrambled to access quality data within an overwhelming quantity of information. As global curated data sets emerged, derivative works such as visualizations or models were developed that depended on consistent data and would fail when there were unanticipated changes. Crowdsourcing was used to collect and analyze data, aid in contact tracing, and produce personal protective equipment by sharing open designs for 3D printing. An international consortium of entrepreneurs and researchers created a ventilator based on an open-source design. A coalition of nongovernmental organizations and governmental organizations, led by the White House Office of Science and Technology Policy, created a shared open resource of over 200,000 research publications about COVID-19 and subsequently offered cash prizes for the best solutions to 17 key questions involving artificial intelligence. A thread of collaboration weaved throughout the pandemic response, which will shape future efforts. Novel partnerships will cross boundaries to create better processes, products, and solutions to consequential societal challenges.

1 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GBGuillaume Belot
Guillaume Belot
FCFrançois Caya
François Caya
KEKaylee Myhre Errecaborde
Kaylee Myhre Errecaborde
TTTieble Traore
Tieble Traore
BLBrice Lafia
Brice Lafia
SRStephane de la Rocque
Stephane de la Rocque
Collaborative, One Health approaches support governments to effectively prevent, detect and respond to emerging health challenges, such as zoonotic diseases, that arise at the human-animal-environmental interfaces. To overcome these challenges, operational and outcome-oriented tools that enable animal health and human health services to work specifically on their collaboration are required. While international capacity and assessment frameworks such as the IHR-MEF (International Health Regulations—Monitoring and Evaluation Framework) and the OIE PVS (Performance of Veterinary Services) Pathway exist, a tool and process that could assess and strengthen the interactions between human and animal health sectors was needed. Through a series of six phased pilots, the IHR-PVS National Bridging Workshop (NBW) method was developed and refined. The NBW process gathers human and animal health stakeholders and follows seven sessions, scheduled across three days. The outputs from each session build towards the next one, following a structured process that goes from gap identification to joint planning of corrective measures. The NBW process allows human and animal health sector representatives to jointly identify actions that support collaboration while advancing evaluation goals identified through the IHR-MEF and the OIE PVS Pathway. By integrating sector-specific and collaborative goals, the NBWs help countries in creating a realistic, concrete and practical joint road map for enhanced compliance to international standards as well as strengthened preparedness and response for health security at the human-animal interface.

29 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJuliana Leite
Juliana Leite
LGLionel Gresh
Lionel Gresh
AVAndrea Vicari
Andrea Vicari
JGJean Marc Gabastou
Jean Marc Gabastou
EPEnrique Perez
Enrique Perez
JMJairo Mendez-Rico
Jairo Mendez-Rico
By the time the etiologic agent of the COVID-19 was identified as a novel coronavirus, no country in the Americas Region had laboratory capacity for detecting this new virus. A strategic multilevel approach with specific reagent purchase and delivery, regional trainings, in-country missions, and the provision of technical support was established for timely preparedness of national reference laboratories for SARS-CoV-2 detection. All countries should be prepared to timely detect any potential pandemic emerging agent. The rapid SARS-CoV-2 molecular detection implementation throughout the Americas showed the importance of an efficient and coordinated laboratory response for preparedness. Here we present how in 25 days the Americas Region went from no SARS-CoV-2 diagnostic capacity, to molecular detection fully implemented in 28 Member States, under the coordinated strategy of the Pan American Health Organization and collaborative work at regional and country level with national authorities and public health laboratories.

9 July 2019 in Foodborne Pathogens and Disease
Verified
Journal Article
Open access
ICIsabel Chinen
Isabel Chinen
JCJosefina Campos
Josefina Campos
TDTshewang Dorji
Tshewang Dorji
EGEnrique Pérez Gutiérrez
Enrique Pérez Gutiérrez
PulseNet Latin America and Caribbean (PNLAC) was established in 2003 and is one of seven Regional networks within PulseNet International. The main objectives of the network are to strengthen national and regional laboratory-based foodborne disease surveillance for early detection and investigation of outbreaks to setup control and prevention strategies in contribution to Public Health. Participants perform standardized pulsed-field gel electrophoresis (PFGE) protocols and analysis. For functioning, it is important for the network, the development of national and regional databases (RDBs) and the communication between countries, regionally and internationally. Metadata from over 8600 cases/outbreaks are profiled and isolated by PFGE and are incorporated into the RDB, hosted by the Pan American Health Organization. Currently PNLAC is moving toward whole-genome sequencing to use as a complementary strategy for surveillance. The aim of this article was to describe the experience of the construction of PNLAC, and its contribution to the surveillance of the foodborne diseases at the country and regional levels.

16 September 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
PGPaula Diaz Guevara
Paula Diaz Guevara
MMMailis Maes
Mailis Maes
DTDuy Pham Thanh
Duy Pham Thanh
CDCarolina Duarte
Carolina Duarte
EREdna Catering Rodriguez
Edna Catering Rodriguez
SBStephen Baker
Stephen Baker
Little is known about the genetic diversity of Salmonella enterica serovar Typhi (S. Typhi) circulating in Latin America. It has been observed that typhoid fever is still endemic in this part of the world; however, a lack of standardized blood culture surveillance across Latin American makes estimating the true disease burden problematic. The Colombian National Health Service established a surveillance system for tracking bacterial pathogens, including S. Typhi, in 2006. Here, we characterized 77 representative Colombian S. Typhi isolates collected between 1997 and 2018 using pulse field gel electrophoresis (PFGE; the accepted genotyping method in Latin America) and whole genome sequencing (WGS). We found that the main S. Typhi clades circulating in Colombia were clades 2.5 and 3.5. Notably, the sequenced S. Typhi isolates from Colombia were closely related in a global phylogeny. Consequently, these data suggest that these are endemic clades circulating in Colombia. We found that AMR in S. Typhi in Colombia was uncommon, with a small subset of organisms exhibiting mutations associated with reduced susceptibility to fluoroquinolones. This is the first time that S. Typhi isolated from Colombia have been characterized by WGS, and after comparing these data with those generated using PFGE, we conclude that PFGE is unsuitable for tracking S. Typhi clones and mapping transmission. The genetic diversity of pathogens such as S. Typhi is limited in Latin America and should be targeted for future surveillance studies incorporating WGS.